Uterine Corpus Carcinosarcoma
7 clinical trials · Condition
◉ Watch Uterine Corpus Carcinosarcoma
| Record | Firm | Date |
|---|---|---|
| Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers (NCT05049538) | M.D. Anderson Cancer Center | 2019-06-18 |
| Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer (NCT03422198) | University of Utah | 2018-02-02 |
| Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer (NCT02874430) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2016-06-08 |
| Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers (NCT02020707) | Mayo Clinic | 2014-02-24 |
| Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer (NCT01935934) | National Cancer Institute (NCI) | 2013-05-08 |
| Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer (NCT00478426) | National Cancer Institute (NCI) | 2007-04-30 |
Track Uterine Corpus Carcinosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.